Results 91 to 100 of about 294,417 (155)

Nucleic Acid Therapeutics for "Undruggable" Cancer Targets: Mechanisms, Challenges, and Prospects. [PDF]

Adv Sci (Weinh)
Xu F, Wang K, Lu K, Hou T, Chen Y, Wang X, Jin H.   +6 more
europepmc   +1 more source

Oncogene c‑Myc: From molecular mechanism to targeted therapy (Review). [PDF]

Mol Med Rep
Lu J, Zhu J, Zhang L, Zheng X, Yang S, Sang Y, Yang M, Tang Y.   +7 more
europepmc   +1 more source

Pan-cancer 8q24 amplification predicts primary immunotherapy resistance and therapeutic vulnerabilities. [PDF]

iScience
Chen C, Liu S, Feng J, Luo Z, Bi Y, Huang Q, Zhang Y, Yu H, Wu J, Yu H, Liu R, Hu J, Ye L, Zhu Y, He Y, Chen L, Lu L, Gong K.   +17 more
europepmc   +1 more source

Targeting the MYCN interaction network in neuroblastoma. [PDF]

Biosci Rep
Yow CX, Yeoh S, Leen E, Bayliss R.
europepmc   +1 more source

CDC20 promotes prostate cancer progression via modulating c-MYC and PI3K-AKT signaling. [PDF]

iScience
Ding J, Xu X, Zhang N, Chen J, Zhu W, Lu K, Wang C, Fu Z, Zhai J, Wang Y.   +9 more
europepmc   +1 more source

Interrogating the Mechanistic Link between Neighborhood Deprivation and Colorectal Cancer Risk through Transcriptomic Analysis of Normal Colorectal Biopsies. [PDF]

Cancer Epidemiol Biomarkers Prev
Devall MA, Taha HM, Chen M, Eaton SD, Sun X, Venkatesh S, Ramirez A, Habib FZ, Ali MW, Cooper GS, Willis J, Hu G, Ebrahim S, Schmit SL, Peters U, Powell SM, Yoshida C, Li L.   +17 more
europepmc   +1 more source

CA9-Targeted Liposomal Delivery of siETS1 Inhibits Clear Cell Renal Cell Carcinoma Progression by Disrupting the ETS1/MYC Regulatory Axis. [PDF]

Int J Nanomedicine
Ye Y, Sun J, Zhang Y, Wang S, Meng Z.
europepmc   +1 more source

C-MYC as a key effector of WNT, PI3K/AKT, MAPK, and TGF-β signaling pathways in regulation of epithelial-mesenchymal transition during tumor metastasis. [PDF]

Cancer Cell Int
Moghbeli M.
europepmc   +1 more source

PKA signaling modulates PRMT5/hnRNP A1-mediated IRES translation and dictates responses to mTOR inhibition in glioblastoma. [PDF]

J Neurooncol
Kumar S, Benavides-Serrato A, Saunders JT, Nishimura RN, Gera JF.   +4 more
europepmc   +1 more source

KDM8/c-Myc axis-mediated glucose metabolism reprogramming promotes the progression of ovarian cancer. [PDF]

Sci Rep
Liu C, Xu Q, Li Z, Yang X, Mao B, Guo L, Liu X, Liu W.   +7 more
europepmc   +1 more source